Questa organizzazione promuove nuovi trattamenti per la perdita della vista, con soluzioni innovative per chi vive la cecità. Visita FightingBlindness.org per saperne di più.
J&J’s XLRP Gene Therapy Didn’t Meet Primary Endpoint in Phase 3 Clinical Trial
3 mins • May 15, 2025
Charts
- 171Decreased by 8
- 162NEW
- 17Increased by 0
Episodi recenti

May 15, 2025
J&J’s XLRP Gene Therapy Didn’t Meet Primary Endpoint in Phase 3 Clinical Trial
3 mins

May 13, 2025
ARVO 2025 Highlight: PYC Reports Encouraging Phase 1/2 Clinical Trial Results for its RNA Therapy Targeting RP (PRPF31 Mutations)
5 mins

May 12, 2025
ARVO 2025 Highlight: Atsena’s XLRS Gene Therapy Provides Vision and Structural Improvements in Phase 1/2 Clinical Trial
4 mins

May 9, 2025
ARVO 2025 Highlight: Beacon Reports Encouraging Results for Second Eyes Dosed in Clinical Trial for XLRP Gene Therapy
3 mins

May 9, 2025
Eye on the Cure Podcast | Episode 85: Cindy Elden
29 mins

Lingua
Inglese
Paese
Stati Uniti
Categorie
Feed Host
Sito web
Feed
Richiedi un aggiornamento
Gli aggiornamenti potrebbero richiedere alcuni minuti.